apl-1202
Small moleculeexperimental
Clinical trial activity
8 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
5
Phase 3
2
Phase 4
0
Earliest trial started May 13, 2014 (NCT04498702)
Timeline
Indications
Mechanism of action
- Methionine aminopeptidase 2INHIBITOR
METAP2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06435039 | Phase 1 | Jun 26, 2024 | Jiangsu Asieris Pharmaceutical Technology Co., Ltd., Syneos Health |
| NCT06034015 | Phase 1 | Sep 9, 2023 | Jiangsu Asieris Pharmaceutical Technology Co., Ltd. |
| NCT04736394 | Phase 3 | Oct 1, 2021 | Jiangsu Asieris Pharmaceutical Technology Co., Ltd. |
| NCT04813107 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2021 | Jiangsu Asieris Pharmaceutical Technology Co., Ltd. |
| NCT04601766 | Phase 1 | Oct 21, 2020 | Jiangsu Asieris Pharmaceutical Technology Co., Ltd. |
| NCT03672240 | Phase 1/Phase 2 (Phase 2) | Oct 31, 2018 | Accelovance, Jiangsu Asieris Pharmaceutical Technology Co., Ltd. |
| NCT04490993 | Phase 3 | Mar 30, 2017 | Chinese Academy of Medical Sciences, Fudan University |
| NCT04498702 | Phase 2 | May 13, 2014 | Fudan University |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu Asieris Pharmaceutical Technology Co., Ltd. | For profit | 6 | 5 | 3 | 2018 |
| Fudan University | Academic/Hospital | 2 | 0 | 2 | 2014 |
| Accelovance | For profit | 1 | 0 | 1 | 2018 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Syneos Health | For profit | 1 | 1 | 1 | 2024 |
5 organizations
Page 1 / 1